Table 4.
WHO histological classification of salivary gland tumors 2017 (42, 43).
| Benign epithelial tumors | Malignant epithelial tumors |
| Pleomorphic adenoma 8940/0 | Acinic cell carcinoma 8550/3 |
| Myoepithelioma 8982/0 | Mucoepidermoid carcinoma 8430/3 |
| Basal cell adenoma 8147/0 | Adenoid cystic carcinoma 8200/3 |
| Warthin tumor 8561/0 | Polymorphous adenocarcinoma 8525/3 |
| Oncocytoma 8290/0 | Epithelial-myoepithelial carcinoma 8562/3 |
| Canalicular adenoma and other ductal adenomas 8149/0 | Clear cell carcinoma 8310/3 |
| Sebaceous adenoma 8410/0 | Basal cell adenocarcinoma 8147/3 |
| Lymphadenoma | Sebaceous adenocarcinoma 8410/3 |
| Sebaceous 8410/0 | Secretory carcinoma 8502/3 |
| Non-sebaceous 8410/0 | |
| Ductal papillomas 8503/0 | Intraductal carcinoma |
| Oncocytic carcinoma 8290/3 | |
| Sialadenoma papilliferum 8406/0 | Salivary duct carcinoma 8500/3 |
| Cystadenoma 8440/0 | Adenocarcinoma, NOS 8140/3 |
| Myoepithelial carcinoma 8982/3 | |
| Soft tissue tumors | Carcinoma ex pleomorphic adenoma 8941/3 |
| Hemangioma 9120/0 | Poorly differentiated carcinoma 8020/3 |
| Carcinosarcoma 8980/3 | |
| Hematolymphoid tumors | Squamous cell carcinoma 8070/3 |
| Hodgkin lymphoma | |
| Diffuse large B-cell lymphoma 9680/3 | |
| Extranodal marginal zone B-cell lymphoma 9699/3 | Lymphoepithelial carcinoma 8082/3 |
| Hodgkin lymphoma | Sialoblastoma 8974/1 |
| Secondary tumors |